Redmile Group LLC 13D and 13G filings for Kymera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:27 pm Purchase |
2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
Redmile Group LLC | 2,673,837 4.900% |
86,107 (+3.33%) |
Filing |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
Redmile Group LLC | 2,587,730 5.000% |
-132,759 (-4.88%) |
Filing |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
Redmile Group LLC | 2,720,489 6.100% |
2,720,489 (New Position) |
Filing |